New China Life Insurance (1336) Fundamentals 2026 — P/E 5.5x, Revenue Analysis | SniperIQ
New China Life Insurance (1336) is a CN-listed Financial Services company in Insurance - Life with a market capitalization of HK
94.1B, trading at HK$48.40 on the HKSE. This SniperIQ fundamentals page covers New China Life Insurance's valuation (P/E 5.5x, P/B 1.6x), profitability (net margin 25.5%), revenue (¥130.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market CapHK
94.1B
P/E (TTM)5.5x
Net Margin25.5%
Revenue (FY25)¥130.8B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is New China Life Insurance's market cap?
New China Life Insurance (1336) has a market capitalization of approximately HK
94.1B, trading at HK$48.40 on the HKSE. Market cap moves with the live share price.
What is New China Life Insurance's P/E ratio?
New China Life Insurance's trailing twelve-month P/E ratio is 5.5x, with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.
How profitable is New China Life Insurance?
New China Life Insurance runs a net profit margin of 25.5%, a gross margin of 100.0%, and an operating margin of 28.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does New China Life Insurance generate?
New China Life Insurance reported revenue of ¥130.8B for fiscal year 2025, with net income of ¥35.3B and earnings per share (EPS) of 11.33. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does New China Life Insurance pay a dividend?
New China Life Insurance offers a trailing dividend yield of about 4.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is New China Life Insurance financially healthy?
New China Life Insurance carries a debt-to-equity ratio of 1.03x and a current ratio of 0.00x, with a market beta of 0.87. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is New China Life Insurance a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For New China Life Insurance (1336) the key facts are: market cap HK
94.1B, P/E 5.5x, revenue ¥130.8B, 52-week range 41.46-65.8. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.
Track New China Life Insurance's full fundamentals live
Get New China Life Insurance's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.